Raffles Medical’s profit after tax soars 71.7% YoY to $143.7m in FY22

The company attributed the increase to the return of foreign patients.

Raffles Medical Group saw a 71.7% YoY increase in its profit after tax (PAT) for FY22 following the return of foreign patients seeking medical treatment in Singapore.

Based on its latest financial statement, Raffles Medical Group’s profit after tax in FY22 was $143.7m.

During the financial year, the company also recorded a 5.9% YoY higher revenue of $766.5m.

Given the increase in its profit after tax and revenue, as well as a healthy cash position of $252.1m, the group's directors proposed a final ordinary dividend of $0.038 per share for FY22.

The final dividend for FY22 represents a 35.7% YoY increase from FY21.

Follow the link for more news on

Raffles Medical Group

Financial Statements

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia